Skip to main content

Peer Review reports

From: Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial

Original Submission
1 Jun 2021 Submitted Original manuscript
7 Jun 2021 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
9 Jun 2021 Editorially accepted
6 Jul 2021 Article published 10.1186/s13063-021-05363-w

You can find further information about peer review here.

Back to article page